1. Home
  2. NX vs AVDL Comparison

NX vs AVDL Comparison

Compare NX & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NX
  • AVDL
  • Stock Information
  • Founded
  • NX 1927
  • AVDL 2015
  • Country
  • NX United States
  • AVDL Ireland
  • Employees
  • NX N/A
  • AVDL N/A
  • Industry
  • NX Metal Fabrications
  • AVDL Biotechnology: Pharmaceutical Preparations
  • Sector
  • NX Industrials
  • AVDL Health Care
  • Exchange
  • NX Nasdaq
  • AVDL Nasdaq
  • Market Cap
  • NX 852.8M
  • AVDL 784.6M
  • IPO Year
  • NX N/A
  • AVDL 1996
  • Fundamental
  • Price
  • NX $20.51
  • AVDL $8.93
  • Analyst Decision
  • NX Strong Buy
  • AVDL Strong Buy
  • Analyst Count
  • NX 1
  • AVDL 6
  • Target Price
  • NX $38.00
  • AVDL $18.17
  • AVG Volume (30 Days)
  • NX 580.4K
  • AVDL 1.7M
  • Earning Date
  • NX 06-05-2025
  • AVDL 08-07-2025
  • Dividend Yield
  • NX 1.56%
  • AVDL N/A
  • EPS Growth
  • NX N/A
  • AVDL N/A
  • EPS
  • NX 0.39
  • AVDL N/A
  • Revenue
  • NX $1,625,028,000.00
  • AVDL $194,450,000.00
  • Revenue This Year
  • NX $49.00
  • AVDL $56.88
  • Revenue Next Year
  • NX $2.99
  • AVDL $29.81
  • P/E Ratio
  • NX $52.20
  • AVDL N/A
  • Revenue Growth
  • NX 47.66
  • AVDL 252.64
  • 52 Week Low
  • NX $15.30
  • AVDL $6.38
  • 52 Week High
  • NX $34.97
  • AVDL $17.30
  • Technical
  • Relative Strength Index (RSI)
  • NX 62.34
  • AVDL 41.81
  • Support Level
  • NX $18.75
  • AVDL $8.52
  • Resistance Level
  • NX $19.66
  • AVDL $8.94
  • Average True Range (ATR)
  • NX 0.79
  • AVDL 0.41
  • MACD
  • NX 0.17
  • AVDL -0.11
  • Stochastic Oscillator
  • NX 75.86
  • AVDL 25.98

About NX Quanex Building Products Corporation

Quanex Building Products Corp is a manufacturer of components sold to original equipment manufacturers in the building products industry. It manufactures engineered products like window and door components that include flexible insulating glass spacers, extruded vinyl profiles, window and door screens, solar panel sealants and precision-formed metal and wood products among others. Its four operating segments are North American Fenestration being the key revenue driver, European Fenestration, North American Cabinet Components, and Tyman. Geographically, it derives a majority of revenue from the United States.

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

Share on Social Networks: